Courtesy of ISMRM
PHILADELPHIA –
Felix W. Wehrli, PhD, a professor of radiologic science, biochemistry and biophysics in the department of Radiology, was recently honored by the
International Society for Magnetic Resonance in Medicine (ISMRM) with the Society's Gold Medal Award during its 2017 Annual Meeting and Exhibition. This award recognizes major research contributions to the field of magnetic resonance imaging.
An international nonprofit scientific association, the ISMRM’s mission is to advance communication, research, development, and applications in the area of magnetic resonance in medicine and biology and other similar topics. Its multidisciplinary membership consists of more than 9,000 clinicians, physicists, engineers, biochemists, and technologists. Along with holding scientific meetings and providing opportunities for continuing education, the Society hosts workshops and publishes two journals, Magnetic Resonance in Medicine and the Journal of Magnetic Resonance Imaging, and sponsors local areas chapters and 24 study groups.
Wehrli, who is also director of the Laboratory for Structural, Physiologic and Functional Imaging, earned a MS and PhD in chemistry from the Swiss Federal Institute of Technology. His research focuses on the conception, implementation and translation to the clinic of new quantitative imaging methods by MRI. Research in his laboratory has been continuously funded by the National Institutes of Health for over 25 years. Wehrli’s work has significantly expanded the body of knowledge on quantitatively characterizing tissue microarchitecture in vivo by MRI methods and relating these data to human physiology, function and pathology. Of note is his pioneering work on the development of new MRI techniques for evaluating metabolic bone disease and, more recently, the study of systemic vascular disease and quantitative assessment of oxygen metabolism in the brain.
Penn Medicine is one of the world’s leading academic medical centers, dedicated to the related missions of medical education, biomedical research, excellence in patient care, and community service. The organization consists of the University of Pennsylvania Health System and Penn’s Raymond and Ruth Perelman School of Medicine, founded in 1765 as the nation’s first medical school.
The Perelman School of Medicine is consistently among the nation's top recipients of funding from the National Institutes of Health, with $550 million awarded in the 2022 fiscal year. Home to a proud history of “firsts” in medicine, Penn Medicine teams have pioneered discoveries and innovations that have shaped modern medicine, including recent breakthroughs such as CAR T cell therapy for cancer and the mRNA technology used in COVID-19 vaccines.
The University of Pennsylvania Health System’s patient care facilities stretch from the Susquehanna River in Pennsylvania to the New Jersey shore. These include the Hospital of the University of Pennsylvania, Penn Presbyterian Medical Center, Chester County Hospital, Lancaster General Health, Penn Medicine Princeton Health, and Pennsylvania Hospital—the nation’s first hospital, founded in 1751. Additional facilities and enterprises include Good Shepherd Penn Partners, Penn Medicine at Home, Lancaster Behavioral Health Hospital, and Princeton House Behavioral Health, among others.
Penn Medicine is an $11.1 billion enterprise powered by more than 49,000 talented faculty and staff.